Investor s Fiduciary Advisor Network LLC purchased a new stake in The Procter & Gamble Company (NYSE:PG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,981 shares of the company's stock, valued at approximately $1,338,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Regent Peak Wealth Advisors LLC increased its stake in shares of Procter & Gamble by 1.3% in the 4th quarter. Regent Peak Wealth Advisors LLC now owns 11,063 shares of the company's stock valued at $1,855,000 after buying an additional 139 shares during the period. ORG Partners LLC increased its position in Procter & Gamble by 5.6% in the fourth quarter. ORG Partners LLC now owns 5,618 shares of the company's stock worth $943,000 after purchasing an additional 300 shares during the period. Harbor Capital Advisors Inc. raised its holdings in Procter & Gamble by 2.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 33,647 shares of the company's stock worth $5,641,000 after purchasing an additional 822 shares during the last quarter. Czech National Bank lifted its position in Procter & Gamble by 6.5% during the 4th quarter. Czech National Bank now owns 510,620 shares of the company's stock valued at $85,605,000 after purchasing an additional 31,075 shares during the period. Finally, Aprio Wealth Management LLC boosted its stake in shares of Procter & Gamble by 13.3% in the 4th quarter. Aprio Wealth Management LLC now owns 9,509 shares of the company's stock valued at $1,594,000 after purchasing an additional 1,119 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $157.73 on Friday. The Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43. The company has a market cap of $369.80 billion, a PE ratio of 25.12, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The business's 50 day moving average price is $165.92 and its two-hundred day moving average price is $167.56. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business had revenue of $19.78 billion during the quarter, compared to the consensus estimate of $20.42 billion. During the same quarter last year, the firm posted $1.52 EPS. The company's quarterly revenue was down 2.1% on a year-over-year basis. On average, analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Monday, April 21st will be issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.68%. The ex-dividend date is Monday, April 21st. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's payout ratio is currently 66.98%.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on the stock. Piper Sandler increased their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a report on Monday, May 5th. UBS Group restated a "buy" rating on shares of Procter & Gamble in a research report on Monday, February 10th. Morgan Stanley set a $180.00 target price on Procter & Gamble and gave the company an "overweight" rating in a research note on Friday, April 25th. Erste Group Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Citigroup cut their price target on shares of Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Eight equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $178.52.
Check Out Our Latest Stock Report on Procter & Gamble
Insider Activity
In other Procter & Gamble news, CEO Gary A. Coombe sold 35,000 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the transaction, the chief executive officer now owns 22,051 shares in the company, valued at $3,829,817.68. This trade represents a 61.35 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares of the company's stock, valued at approximately $8,386,111.70. The trade was a 1.89 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 64,520 shares of company stock valued at $10,999,268. 0.18% of the stock is owned by insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report